Theriva Biologics Inc.
(TOVX)
undefined
undefined%
At close: undefined
1.18
1.29%
After-hours Dec 13, 2024, 06:30 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 | FY93 |
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.16M | 103.09K | - | - | - | - | 10.00K | 874.10K | 506.57K | 399.38K | 400.00K | 500.00K | 500.00K | 100.00K | 100.00K | 100.00K |
Cost of Revenue | 135.00K | 268.00K | 87.00K | 201.00K | 240.00K | 272.00K | 245.00K | 157.00K | 72.00K | - | - | - | - | 467.62K | - | - | - | - | - | - | - | 118.78K | 86.34K | 100.00K | 100.00K | 100.00K | - | - | 100.00K |
Gross Profit | -135.00K | -268.00K | -87.00K | -201.00K | -240.00K | -272.00K | -245.00K | -157.00K | -72.00K | - | - | - | - | 2.70M | 103.09K | - | - | - | - | 10.00K | 874.10K | 387.80K | 313.04K | 300.00K | 400.00K | 400.00K | 100.00K | 100.00K | - |
Operating Income | -21.43M | -21.58M | -14.27M | -10.16M | -15.66M | -17.57M | -26.25M | -39.25M | -40.98M | -20.50M | -12.34M | -17.30M | -5.93M | -1.58M | -3.68M | -7.32M | -10.14M | -4.12M | -1.36M | -8.09M | -9.68M | -6.30M | 9.70M | 8.20M | -9.60M | -7.30M | -7.30M | -6.40M | -3.40M |
Interest Income | 1.44M | 512.00K | 6.00K | 44.00K | 283.00K | 67.00K | 21.00K | 37.00K | 6.00K | 3.00K | 33.00K | 33.00K | 14.00K | 413.00 | 2.96K | 128.24K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -19.99M | -21.11M | -14.27M | -10.12M | -15.38M | -13.42M | -15.49M | -27.80M | -44.78M | -19.78M | -12.32M | -17.28M | -7.63M | -1.71M | -3.72M | -7.32M | - | -4.13M | -1.39M | - | -9.60M | -6.06M | -5.30M | -5.00M | -9.50M | -7.20M | - | -6.30M | -3.50M |
Net Income | -18.35M | -19.68M | -14.17M | -10.00M | -15.02M | -13.37M | -15.17M | -27.25M | -43.74M | -19.78M | -12.32M | -17.07M | -8.15M | -1.71M | -3.73M | -7.21M | -9.89M | -4.10M | -1.36M | -8.62M | -9.48M | -5.76M | -17.38M | -18.60M | -9.50M | -7.00M | -7.40M | -6.30M | -3.90M |
Selling & General & Admin | 7.78M | 9.86M | 6.47M | 5.03M | 4.58M | 5.73M | 7.47M | 10.14M | 8.07M | 6.01M | 5.83M | 5.01M | 2.59M | 2.70M | 2.58M | 2.68M | 3.81M | 1.44M | 285.70K | 4.48M | 4.55M | 2.82M | 2.28M | 3.00M | 4.60M | 7.70M | 3.00M | 6.40M | 3.60M |
Research & Development | 14.31M | 11.72M | 7.80M | 5.13M | 11.08M | 11.84M | 18.78M | 29.11M | 32.91M | 14.49M | 6.51M | 12.29M | 3.34M | 1.58M | 1.20M | 4.64M | 6.33M | 2.67M | 946.07K | 3.62M | 6.00M | 3.75M | 3.42M | 2.40M | 5.40M | - | 4.40M | - | - |
Other Expenses | -660.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 21.43M | 21.58M | 14.27M | 10.16M | 15.66M | 17.57M | 26.25M | 39.25M | 40.98M | 20.50M | 12.34M | 17.30M | 5.93M | 4.28M | 3.78M | 7.32M | 10.14M | 4.10M | 1.32M | 8.26M | 10.68M | 6.68M | 5.79M | 5.50M | 10.10M | 7.80M | 7.40M | 6.40M | 3.70M |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.11K | 9.88K | 13.83K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | 624.00K | - | - | - | - | - | - | - | - | - | 763.00K | 5.01M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 21.43M | 21.58M | 14.27M | 10.16M | 15.66M | 17.57M | 26.25M | 39.25M | 40.98M | 20.50M | 12.34M | 17.30M | 5.93M | 4.75M | 3.78M | 7.32M | 10.14M | 4.10M | 1.32M | 8.26M | 10.68M | 6.80M | 5.87M | 5.60M | 10.20M | 7.90M | 7.40M | 6.40M | 3.80M |
Income Tax | -1.64M | -1.43M | -94.00K | -117.00K | -360.00K | -4.20M | -11.08M | -12.00M | 2.76M | -718.00K | -22.00K | -231.00K | 2.22M | 10.11K | 49.92K | -114.05K | -245.88K | -5.48K | 36.63K | 677.06K | -67.57K | -295.25K | 12.09M | 13.60M | - | -200.00K | 7.40M | - | 400.00K |
Shares Outstanding (Basic) | 644.00K | 613.09K | 12.19M | 1.90M | 1.64M | 623.24K | 355.33K | 269.40K | 230.58K | 176.98K | 130.48K | 99.70K | 79.17K | 63.98K | 60.91K | 59.00K | 50.28K | 9.27K | 1.38K | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Diluted) | 644.28K | 613.09K | 12.19M | 1.90M | 1.64M | 623.24K | 355.33K | 269.40K | 230.58K | 176.98K | 130.48K | 99.70K | 79.17K | 63.98K | 60.91K | 59.00K | 50.28K | 9.27K | 1.38K | - | - | - | - | - | - | - | - | - | - |
EPS (Basic) | -28.49 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 | -171.19 | -102.93 | -26.75 | -61.26 | -122.12 | -196.76 | -442.24 | -982.49 | - | - | - | - | - | - | - | - | - | - |
EPS (Diluted) | -28.48 | -32.11 | -1.16 | -5.26 | -9.14 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 | -171.19 | -102.93 | -26.75 | -61.26 | -122.12 | -196.76 | -442.24 | -982.49 | - | - | - | - | - | - | - | - | - | - |
EBITDA | -19.85M | -21.58M | -14.19M | -9.96M | -15.42M | -17.30M | -26.01M | -39.09M | -40.91M | -20.48M | -11.53M | -17.22M | -7.48M | -1.22M | -3.34M | -6.91M | -9.94M | -4.07M | -1.28M | -8.09M | -9.76M | -6.42M | -5.39M | -5.15M | -7.90M | -7.40M | -7.30M | -6.30M | -3.60M |
Depreciation & Amortization | 135.00K | 268.00K | 87.00K | 201.00K | 240.00K | 272.00K | 245.00K | 157.00K | 72.00K | 20.00K | 43.00K | 63.00K | 201.00K | 358.71K | 382.09K | 404.62K | 199.63K | 30.68K | 2.26K | -154.13K | -130.55K | -118.78K | -86.34K | -100.00K | -100.00K | -100.00K | - | - | -100.00K |